Combined secondary prevention after hospitalization for myocardial infarction in France: Analysis from a large administrative database

Aouba, 2008, Mortalité par maladies de l’appareil circulatoire en 2005 et évolution depuis 1980, Actualite et dossier en sante publique, 69, 25 Arveiler, 2005, Trends in coronary heart disease in France during the second half of the 1990s, Eur J Cardiovasc Prev Rehabil, 12, 209, 10.1097/01.hjr.0000160603.49386.92 Ferrières, 2007, Épidémiologie du syndrome coronaire aigu en France, Ann Cardiol Angeiol, 56, S8, 10.1016/S0003-3928(07)80021-7 Haute Autorité de Santé, HAS. Maladie coronarienne. Guide - affection de longue durée, mars 2007. www.has-sante.fr. Fidan, 2007, Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000–2010, QJM, 100, 277, 10.1093/qjmed/hcm020 Yan, 2007, Canadian ACS Registries Investigators. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome, Am Heart J, 154, 1108, 10.1016/j.ahj.2007.07.040 Setoguchi, 2008, Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis, J Am Coll Cardiol, 51, 1247, 10.1016/j.jacc.2007.10.063 Rasmussen, 2008, Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995–2004, Med Care, 46, 70, 10.1097/MLR.0b013e3181484952 Goldberg, 2007, Global Registry of Acute Coronary Events Investigators. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective, Arch Intern Med, 167, 1766, 10.1001/archinte.167.16.1766 Birkhead, 2004, National Audit of Myocardial Infarction Project Steering Group. Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP), Heart, 90, 1004, 10.1136/hrt.2004.034470 Lee, 2008, Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge, J Manag Care Pharm, 14, 271 Winkelmayer, 2008, Pharmacoeconomics Advisory Council of the Austrian Sickness Funds. Use of recommended medications after myocardial infarction in Austria, Eur J Epidemiol, 23, 153, 10.1007/s10654-007-9212-4 Schoenenberger, 2008, Acute Myocardial Infarction in Switzerland Plus Investigators. Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study, J Am Geriatr Soc, 56, 510, 10.1111/j.1532-5415.2007.01589.x Setoguchi, 2007, Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age, Am J Cardiol, 100, 1061, 10.1016/j.amjcard.2007.04.052 Alexander, 2005, CRUSADE Investigators. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative, J Am Coll Cardiol, 46, 1479, 10.1016/j.jacc.2005.05.084 Avezum, 2005, GRACE Investigators. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE), Am Heart J, 149, 67, 10.1016/j.ahj.2004.06.003 Yan, 2006, Canadian Acute Coronary Syndromes (ACS) Registry Investigators. Age-related differences in the management and outcome of patients with acute coronary syndromes, Am Heart J, 151, 352, 10.1016/j.ahj.2005.03.039 Blomkalns, 2005, J Am Coll Cardiol., 45, 832, 10.1016/j.jacc.2004.11.055 Yan, 2006, Canadian Acute Coronary Syndrome Registry Investigators. Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes, Am Heart J, 152, 676, 10.1016/j.ahj.2006.04.002 Anselmino, 2008, Euro Heart Survey Investigators. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart, Eur J Cardiovasc Prev Rehabil, 15, 216, 10.1097/HJR.0b013e3282f335d0 Turley, 2008, Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up, Interact Cardiovasc Thorac Surg, 7, 231, 10.1510/icvts.2007.168948 Birkhead, 2006, Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004-5: observational study, BMJ, 332, 1306, 10.1136/bmj.38849.440914.AE Newby, 2006, Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease, Circulation, 113, 203, 10.1161/CIRCULATIONAHA.105.505636 Jackevicius, 2008, Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction, Circulation, 117, 1028, 10.1161/CIRCULATIONAHA.107.706820 Amar, 2008, Persistence of combination of evidence-based medical therapy in patients with acute coronary syndromes, Arch Cardiovasc Dis, 101, 301, 10.1016/j.acvd.2008.04.005 Danchin, 2005, for the USIC 2000 investigators. Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry, Am Heart J, 150, 1147, 10.1016/j.ahj.2005.01.058 Danchin, 2009, Ferrières Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey, Int J Cardiol, 133, 32, 10.1016/j.ijcard.2007.11.060 Moriel, 2008, Contemporary treatment and adherence to guidelines in women and men with acute coronary syndromes, Int J Cardiol, 131, 97, 10.1016/j.ijcard.2007.09.005 Milcent, 2007, Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database, Circulation, 115, 833, 10.1161/CIRCULATIONAHA.106.664979 Shepherd, 2002, Westendorp RG; PROSPER study group. Prospective Study of Pravastatin in the Elderly at Risk, Lancet, 360, 1623, 10.1016/S0140-6736(02)11600-X Shah, 2008, Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients > or = 65 years of age with heart failure and preserved left ventricular systolic function, Am J Cardiol, 101, 217, 10.1016/j.amjcard.2007.08.050 Ganz, 2000, Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction, Ann Intern Med, 132, 780, 10.7326/0003-4819-132-10-200005160-00003 Ko, 2004, Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox, JAMA, 291, 1864, 10.1001/jama.291.15.1864 Danchin, 2002, Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey, Heart, 88, 159, 10.1136/heart.88.2.159